Recombinant FVIII Market
1 Recombinant FVIII Market Overview
1.1 Product Overview and Scope of Recombinant FVIII
1.2 Recombinant FVIII Segment by Type
1.2.1 Global Recombinant FVIII Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 250 IU/bottle
1.2.3 500 IU/bottle
1.2.4 1000 IU/bottle
1.2.5 2000 IU/bottle
1.3 Recombinant FVIII Segment by Application
1.3.1 Global Recombinant FVIII Sales Comparison by Application: (2022-2028)
1.3.2 Teenagers
1.3.3 Adults
1.4 Global Recombinant FVIII Market Size Estimates and Forecasts
1.4.1 Global Recombinant FVIII Revenue 2017-2028
1.4.2 Global Recombinant FVIII Sales 2017-2028
1.4.3 Recombinant FVIII Market Size by Region: 2017 Versus 2021 Versus 2028
2 Recombinant FVIII Market Competition by Manufacturers
2.1 Global Recombinant FVIII Sales Market Share by Manufacturers (2017-2022)
2.2 Global Recombinant FVIII Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Recombinant FVIII Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Recombinant FVIII Manufacturing Sites, Area Served, Product Type
2.5 Recombinant FVIII Market Competitive Situation and Trends
2.5.1 Recombinant FVIII Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Recombinant FVIII Players Market Share by Revenue
2.5.3 Global Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant FVIII Retrospective Market Scenario by Region
3.1 Global Recombinant FVIII Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Recombinant FVIII Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Recombinant FVIII Market Facts & Figures by Country
3.3.1 North America Recombinant FVIII Sales by Country
3.3.2 North America Recombinant FVIII Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Recombinant FVIII Market Facts & Figures by Country
3.4.1 Europe Recombinant FVIII Sales by Country
3.4.2 Europe Recombinant FVIII Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Recombinant FVIII Market Facts & Figures by Region
3.5.1 Asia Pacific Recombinant FVIII Sales by Region
3.5.2 Asia Pacific Recombinant FVIII Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Recombinant FVIII Market Facts & Figures by Country
3.6.1 Latin America Recombinant FVIII Sales by Country
3.6.2 Latin America Recombinant FVIII Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Recombinant FVIII Market Facts & Figures by Country
3.7.1 Middle East and Africa Recombinant FVIII Sales by Country
3.7.2 Middle East and Africa Recombinant FVIII Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Recombinant FVIII Historic Market Analysis by Type
4.1 Global Recombinant FVIII Sales Market Share by Type (2017-2022)
4.2 Global Recombinant FVIII Revenue Market Share by Type (2017-2022)
4.3 Global Recombinant FVIII Price by Type (2017-2022)
5 Global Recombinant FVIII Historic Market Analysis by Application
5.1 Global Recombinant FVIII Sales Market Share by Application (2017-2022)
5.2 Global Recombinant FVIII Revenue Market Share by Application (2017-2022)
5.3 Global Recombinant FVIII Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bayer Recombinant FVIII Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Baxter Recombinant FVIII Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Comirnaty
6.3.1 Comirnaty Corporation Information
6.3.2 Comirnaty Description and Business Overview
6.3.3 Comirnaty Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Comirnaty Recombinant FVIII Product Portfolio
6.3.5 Comirnaty Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Corporation Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novo Nordisk Recombinant FVIII Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Green Cross
6.5.1 Green Cross Corporation Information
6.5.2 Green Cross Description and Business Overview
6.5.3 Green Cross Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Green Cross Recombinant FVIII Product Portfolio
6.5.5 Green Cross Recent Developments/Updates
6.6 Sinocelltech
6.6.1 Sinocelltech Corporation Information
6.6.2 Sinocelltech Description and Business Overview
6.6.3 Sinocelltech Recombinant FVIII Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sinocelltech Recombinant FVIII Product Portfolio
6.6.5 Sinocelltech Recent Developments/Updates
7 Recombinant FVIII Manufacturing Cost Analysis
7.1 Recombinant FVIII Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant FVIII
7.4 Recombinant FVIII Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Recombinant FVIII Distributors List
8.3 Recombinant FVIII Customers
9 Recombinant FVIII Market Dynamics
9.1 Recombinant FVIII Industry Trends
9.2 Recombinant FVIII Market Drivers
9.3 Recombinant FVIII Market Challenges
9.4 Recombinant FVIII Market Restraints
10 Global Market Forecast
10.1 Recombinant FVIII Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Recombinant FVIII by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Recombinant FVIII by Type (2023-2028)
10.2 Recombinant FVIII Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Recombinant FVIII by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Recombinant FVIII by Application (2023-2028)
10.3 Recombinant FVIII Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Recombinant FVIII by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Recombinant FVIII by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Recombinant FVIII Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Recombinant FVIII Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Recombinant FVIII Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Recombinant FVIII Market Competitive Situation by Manufacturers in 2021
Table 5. Global Recombinant FVIII Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Recombinant FVIII Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Recombinant FVIII Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Recombinant FVIII Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Recombinant FVIII Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Recombinant FVIII Manufacturing Sites and Area Served
Table 11. Manufacturers Recombinant FVIII Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Recombinant FVIII by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant FVIII as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Recombinant FVIII Sales by Region (2017-2022) & (K Units)
Table 16. Global Recombinant FVIII Sales Market Share by Region (2017-2022)
Table 17. Global Recombinant FVIII Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Recombinant FVIII Revenue Market Share by Region (2017-2022)
Table 19. North America Recombinant FVIII Sales by Country (2017-2022) & (K Units)
Table 20. North America Recombinant FVIII Sales Market Share by Country (2017-2022)
Table 21. North America Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Recombinant FVIII Revenue Market Share by Country (2017-2022)
Table 23. Europe Recombinant FVIII Sales by Country (2017-2022) & (K Units)
Table 24. Europe Recombinant FVIII Sales Market Share by Country (2017-2022)
Table 25. Europe Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Recombinant FVIII Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Recombinant FVIII Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Recombinant FVIII Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Recombinant FVIII Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Recombinant FVIII Revenue Market Share by Region (2017-2022)
Table 31. Latin America Recombinant FVIII Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Recombinant FVIII Sales Market Share by Country (2017-2022)
Table 33. Latin America Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Recombinant FVIII Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Recombinant FVIII Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Recombinant FVIII Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Recombinant FVIII Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Recombinant FVIII Revenue Market Share by Country (2017-2022)
Table 39. Global Recombinant FVIII Sales by Type (2017-2022) & (K Units)
Table 40. Global Recombinant FVIII Sales Market Share by Type (2017-2022)
Table 41. Global Recombinant FVIII Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Recombinant FVIII Revenue Share by Type (2017-2022)
Table 43. Global Recombinant FVIII Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Recombinant FVIII Sales (K Units) by Application (2017-2022)
Table 45. Global Recombinant FVIII Sales Market Share by Application (2017-2022)
Table 46. Global Recombinant FVIII Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Recombinant FVIII Revenue Share by Application (2017-2022)
Table 48. Global Recombinant FVIII Price by Application (2017-2022) & (US$/Unit)
Table 49. Bayer Corporation Information
Table 50. Bayer Description and Business Overview
Table 51. Bayer Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Bayer Recombinant FVIII Product
Table 53. Bayer Recent Developments/Updates
Table 54. Baxter Corporation Information
Table 55. Baxter Description and Business Overview
Table 56. Baxter Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Baxter Recombinant FVIII Product
Table 58. Baxter Recent Developments/Updates
Table 59. Comirnaty Corporation Information
Table 60. Comirnaty Description and Business Overview
Table 61. Comirnaty Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Comirnaty Recombinant FVIII Product
Table 63. Comirnaty Recent Developments/Updates
Table 64. Novo Nordisk Corporation Information
Table 65. Novo Nordisk Description and Business Overview
Table 66. Novo Nordisk Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Novo Nordisk Recombinant FVIII Product
Table 68. Novo Nordisk Recent Developments/Updates
Table 69. Green Cross Corporation Information
Table 70. Green Cross Description and Business Overview
Table 71. Green Cross Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Green Cross Recombinant FVIII Product
Table 73. Green Cross Recent Developments/Updates
Table 74. Sinocelltech Corporation Information
Table 75. Sinocelltech Description and Business Overview
Table 76. Sinocelltech Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Sinocelltech Recombinant FVIII Product
Table 78. Sinocelltech Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Recombinant FVIII Distributors List
Table 82. Recombinant FVIII Customers List
Table 83. Recombinant FVIII Market Trends
Table 84. Recombinant FVIII Market Drivers
Table 85. Recombinant FVIII Market Challenges
Table 86. Recombinant FVIII Market Restraints
Table 87. Global Recombinant FVIII Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Recombinant FVIII Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Recombinant FVIII Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 90. Global Recombinant FVIII Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Recombinant FVIII Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Recombinant FVIII Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Recombinant FVIII Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 94. Global Recombinant FVIII Revenue Market Share Forecast by Application (2023-2028)
Table 95. Global Recombinant FVIII Sales Forecast by Region (2023-2028) & (K Units)
Table 96. Global Recombinant FVIII Sales Market Share Forecast by Region (2023-2028)
Table 97. Global Recombinant FVIII Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 98. Global Recombinant FVIII Revenue Market Share Forecast by Region (2023-2028)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant FVIII
Figure 2. Global Recombinant FVIII Market Share by Type in 2021 & 2028
Figure 3. 250 IU/bottle Product Picture
Figure 4. 500 IU/bottle Product Picture
Figure 5. 1000 IU/bottle Product Picture
Figure 6. 2000 IU/bottle Product Picture
Figure 7. Global Recombinant FVIII Market Share by Application in 2021 & 2028
Figure 8. Teenagers
Figure 9. Adults
Figure 10. Global Recombinant FVIII Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Recombinant FVIII Market Size (2017-2028) & (US$ Million)
Figure 12. Global Recombinant FVIII Sales (2017-2028) & (K Units)
Figure 13. Recombinant FVIII Sales Share by Manufacturers in 2021
Figure 14. Global Recombinant FVIII Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Recombinant FVIII Players: Market Share by Revenue in 2021
Figure 16. Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Recombinant FVIII Sales Market Share by Region (2017-2022)
Figure 18. Global Recombinant FVIII Sales Market Share by Region in 2021
Figure 19. Global Recombinant FVIII Revenue Market Share by Region (2017-2022)
Figure 20. Global Recombinant FVIII Revenue Market Share by Region in 2021
Figure 21. United States Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Recombinant FVIII Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Recombinant FVIII by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Recombinant FVIII
Figure 45. Manufacturing Process Analysis of Recombinant FVIII
Figure 46. Recombinant FVIII Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
